The Roles of PCSK9 in Alzheimer’s Disease: A Systematic Review of Clinical, Genetic, and Preclinical Evidence
Alzheimer’s disease (AD) is increasingly associated with alterations in cholesterol metabolism. Proprotein convertase subtilisin/kexin type 9 (PCSK9), an enzyme regulating low-density lipoprotein receptor (LDLR) degradation, has been implicated in AD through mechanisms involving amyloid-β (Aβ) proce...
Gardado en:
| Principais autores: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
MDPI AG
2025-12-01
|
| Series: | Life |
| Assuntos: | |
| Acceso en liña: | https://www.mdpi.com/2075-1729/15/12/1851 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|
